• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The novel strategy to treat atherosclerotic disease using anti-inflammatory lipid mediators

Research Project

Project/Area Number 25893053
Research Category

Grant-in-Aid for Research Activity Start-up

Allocation TypeSingle-year Grants
Research Field Cardiovascular surgery
Research InstitutionThe University of Tokyo

Principal Investigator

MIYAHARA TAKUYA  東京大学, 医学部附属病院, 助教 (20704943)

Research Collaborator MAKINO Yoshihisa  東京大学, 血管外科
Project Period (FY) 2013-08-30 – 2015-03-31
Project Status Completed (Fiscal Year 2014)
Budget Amount *help
¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Fiscal Year 2014: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Keywords抗炎症性脂質メディエーター / 内膜肥厚 / 動脈硬化 / 動脈瘤
Outline of Final Research Achievements

To investigate the effect of anti-inflammatory lipid mediators on the intimal hyperplasia, we used a balloon injury model of the rat carotid artery. Resolvin D1 or protectin D was administered to the rat by iv-injection at two time points, just after injury and 2 days after injury, and normal saline (0.1% ethanol) was also injected as a control vehicle in the control group. We sacrificed the rat two weeks after injury and compared the intimal hyperplasia between the treated group and the control group. We used intima/media ratio (I/M ratio) to examine the intimal hyperplasia. The intimal hyperplasia was significantly attenuated in the treated vessels as compared to control vessels (control group (n=5), NI/M ratio=1.22±0.26 vs. Resolvin D1 group (n=6), NI/M ratio=0.85±0.14, p=0.031). We are repeating these experiments using the additional animal models and also statistically comparing the intimal hyperplasia between two groups.

Report

(3 results)
  • 2014 Annual Research Report   Final Research Report ( PDF )
  • 2013 Annual Research Report

URL: 

Published: 2013-09-12   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi